We found significantly increased levels of VEGF-A, HGF, and vimentin in primary GBM (pre-surgery) as compared with healthy controls, and higher levels of these proteins associated with worse patient outcome (Additional file 4B-D). The gene discussed is VEGFA; the disease is glioblastoma.